GB1370905A - Local anaesthetic composition - Google Patents

Local anaesthetic composition

Info

Publication number: GB1370905A
Authority: GB; United Kingdom
Prior art keywords: local anaesthetic; anaesthetic composition; composition; local; anaesthetic
Prior art date: 1971-01-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

GB5865971A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Astra USA Inc

Original Assignee

Astra Pharmaceutical Products Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1971-01-26

Filing date

1971-12-17

Publication date

1974-10-16

1971-12-17 Application filed by Astra Pharmaceutical Products Inc filed Critical Astra Pharmaceutical Products Inc

1974-10-16 Publication of GB1370905A publication Critical patent/GB1370905A/en

Status Expired legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)

GB5865971A 1971-01-26 1971-12-17 Local anaesthetic composition Expired GB1370905A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10294271A	1971-01-26	1971-01-26

Publications (1)

Publication Number	Publication Date
GB1370905A true GB1370905A (en)	1974-10-16

Family

ID=22292522

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB5865971A Expired GB1370905A (en)	1971-01-26	1971-12-17	Local anaesthetic composition

Country Status (1)

Country	Link
GB (1)	GB1370905A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995024903A1 (en) *	1994-03-17	1995-09-21	Nanning Maple Leaf Pharmaceutical Co., Ltd.	The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence

1971
- 1971-12-17 GB GB5865971A patent/GB1370905A/en not_active Expired

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995024903A1 (en) *	1994-03-17	1995-09-21	Nanning Maple Leaf Pharmaceutical Co., Ltd.	The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
US5846975A (en) *	1994-03-17	1998-12-08	Nanning Maple Leaf Pharmaceutical Co., Ltd.	Use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence

Similar Documents

Publication	Publication Date	Title
IE36891L (en)	1973-02-24	Coronary-dilating composition
AU5119173A (en)	1974-07-18	Composition
EG10723A (en)	1976-04-30	Substituted para-menthanes
ZA727741B (en)	1973-12-19	Thermofomable compositions
HK57478A (en)	1978-10-06	Photopolymerisable composition
GB1372932A (en)	1974-11-06	Anti-caries compositions
PH10909A (en)	1977-10-04	Esterocyclic compounds and compositions thereof
ZA721353B (en)	1972-11-29	Polyamide-diazo resin composition
ZA724552B (en)	1973-03-28	Antiseborrhoeic compositions
IL38898A0 (en)	1972-05-30	Substituted 3-benzylpyridines
ZA723241B (en)	1973-09-26	Plaster composition
GB1393014A (en)	1975-05-07	Polyurethane-tar compositions
IE35937B1 (en)	1976-07-07	Local anaesthetic composition
ZA721359B (en)	1972-12-27	Substituted thiadiazolidine-diones
IL39336A0 (en)	1972-07-26	Substituted 2-anilinobenzoxazoles
ZA722089B (en)	1973-01-31	Substituted chlorocarbonylureas
JPS5494024A (en)	1979-07-25	Photosensitive composition
GB1391562A (en)	1975-04-23	Resinous composition
GB1370905A (en)	1974-10-16	Local anaesthetic composition
GB1367202A (en)	1974-09-18	Reflex-reflecting compositions
YU282572A (en)	1975-12-31	Kuciste i poklopac kucista
IL38799A0 (en)	1972-04-27	Substituted phenylthiocarbamates
IL39333A0 (en)	1972-07-26	Substituted benzimidazolecarbamates
ZA717795B (en)	1972-08-30	Anesthetic
CY755A (en)	1974-09-10	Therapeutic composition

Legal Events

Date	Code	Title	Description
1975-02-26	PS	Patent sealed
1979-07-18	PCNP	Patent ceased through non-payment of renewal fee